Many diseases are driven by proteins interacting with each other inside cells. But blocking these interactions with drugs is ...

BOSTON--(BUSINESS WIRE)--Mytide Therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has raised $7 million in Series A financing. The round was ...

Modern medicine depends on large, information-rich molecules such as peptides and oligonucleotides. These molecules carry biological instructions that can be directed toward specific disease pathways.

"Many existing methods either involve many time-consuming steps, only work for a narrow set of molecules, or require further manipulations before ready for peptide synthesis," Kohnke said. The new ...